Dendritic Cells Adenovirus-Induced Expression of IL-10 in Increased Survival in Sepsis by In Vivo

[1]  L. Moldawer,et al.  Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[2]  L. Moldawer,et al.  Adenoviral Delivery of Human and Viral IL-10 in Murine Sepsis1 , 2001, The Journal of Immunology.

[3]  J. Banchereau,et al.  Sensing Pathogens and Tuning Immune Responses , 2001, Science.

[4]  K. Matsushima,et al.  Mammalian and Viral IL-10 Enhance C-C Chemokine Receptor 5 but Down-Regulate C-C Chemokine Receptor 7 Expression by Myeloid Dendritic Cells: Impact on Chemotactic Responses and In Vivo Homing Ability1 , 2001, The Journal of Immunology.

[5]  G. Trinchieri,et al.  IL-12 Suppression During Experimental Endotoxin Tolerance: Dendritic Cell Loss and Macrophage Hyporesponsiveness1 , 2001, The Journal of Immunology.

[6]  R. Hotchkiss,et al.  Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans1 , 2001, The Journal of Immunology.

[7]  C. Sousa,et al.  Dendritic cells as sensors of infection. , 2001 .

[8]  L. Moldawer,et al.  Apoptosis in sepsis: a new target for therapeutic exploration , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Giampiero Girolomoni,et al.  Regulatory Activity of Autocrine IL-10 on Dendritic Cell Functions1 , 2001, The Journal of Immunology.

[10]  L. Moldawer,et al.  Considering immunomodulatory therapies in the septic patient: should apoptosis be a potential therapeutic target? , 2001, Immunology letters.

[11]  L. Moldawer,et al.  Extended lung expression and increased tissue localization of viral IL-10 with adenoviral gene therapy. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Link,et al.  Adherent dendritic cells expressing high levels of interleukin‐10 and low levels of interleukin‐12 induce antigen‐specific tolerance to experimental autoimmune encephalomyelitis , 2000, Immunology.

[13]  P. Allavena,et al.  Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys , 2000, Nature Immunology.

[14]  A. Thomson,et al.  Recombinant Adenovirus Induces Maturation of Dendritic Cells via an NF-κB-Dependent Pathway , 2000, Journal of Virology.

[15]  G. Buchan,et al.  Interleukin‐10 does not affect phagocytosis of particulate antigen by bonemarrow‐derived dendritic cells but does impair antigen presentation , 2000, Immunology.

[16]  R. Offringa,et al.  Adenoviruses Activate Human Dendritic Cells without Polarization toward a T-Helper Type 1-Inducing Subset , 1999, Journal of Virology.

[17]  R. Steinman,et al.  Recombinant adenovirus is an efficient and non‐perturbing genetic vector for human dendritic cells , 1999, European journal of immunology.

[18]  T. Standiford,et al.  IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. , 1999, Journal of immunology.

[19]  R. Steinman,et al.  Efficient Presentation of Phagocytosed Cellular Fragments on the Major Histocompatibility Complex Class II Products of Dendritic Cells , 1998, The Journal of experimental medicine.

[20]  G. Trinchieri,et al.  Potent suppression of IL‐12 production from monocytes and dendritic cells during endotoxin tolerance , 1998, European journal of immunology.

[21]  S. Garg,et al.  Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis. , 1998, Critical care medicine.

[22]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[23]  A. Enk,et al.  Induction of tolerance by IL-10-treated dendritic cells. , 1997, Journal of immunology.

[24]  J. Lederer,et al.  Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. , 1997, Annals of surgery.

[25]  D. Klatzmann,et al.  Three populations of mouse lymph node dendritic cells with different origins and dynamics. , 1997, Journal of immunology.

[26]  U. Steckholzer,et al.  Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. , 1997, The Journal of trauma.

[27]  M. Moser,et al.  Effect of interleukin‐10 on dendritic cell maturation and function , 1997, European journal of immunology.

[28]  R. Hotchkiss,et al.  CECAL LIGATION AND PUNCTURE (CLP) INDUCES APOPTOSIS IN THYMUS, SPLEEN, LUNG, AND GUT BY AN ENDOTOXIN AND TNF‐INDEPENDENT PATHWAY , 1997, Shock.

[29]  T. van der Poll,et al.  Interleukin-10 impairs host defense in murine pneumococcal pneumonia. , 1996, The Journal of infectious diseases.

[30]  F. Graham,et al.  Methods for construction of adenovirus vectors , 1995, Molecular biotechnology.

[31]  M. Lamy,et al.  Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. , 1989, Critical care medicine.

[32]  I. Chaudry,et al.  Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. , 1983, Surgery.

[33]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[34]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.